Physical radiotherapy treatment planning based on functional PET/CT data.

Positron emission tomography (PET) provides molecular information about the tumor microenvironment in addition to anatomical imaging. Hence, it seems to be highly beneficial to integrate PET data into radiotherapy (RT) treatment planning. Functional PET images can be used in RT planning following different strategies, with different orders of complexity. In a first instance, PET imaging data can be used for better target volume delineation. A second strategy, dose painting by contours (DPBC), consists of creating an additional PET-based target volume which will then be treated with a higher dose level. In contrast, dose painting by numbers (DPBN) aims for a locally varying dose prescription according to the variation of the PET signal. For both dose painting approaches, isotoxicity planning strategies should be applied in order not to compromise organs at risk compared to conventional modern RT treatment. In terms of physical dose painting treatment planning, several factors that may introduce limitations and uncertainties are of major importance. These are the PET voxel size, uncertainties due to image acquisition and reconstruction, a reproducible image registration, inherent biological uncertainties due to biological and chemical tracer characteristics, accurate dose calculation algorithms and radiation delivery techniques able to apply highly modulated dose distributions. Further research is necessary in order to investigate these factors and their influence on dose painting treatment planning and delivery thoroughly. To date, dose painting remains a theoretical concept which needs further validation. Nevertheless, molecular imaging has the potential to significantly improve target volume delineation and might also serve as a basis for treatment alteration in the future.

[1]  D. Olsen,et al.  Radiotherapy adapted to spatial and temporal variability in tumor hypoxia. , 2007, International journal of radiation oncology, biology, physics.

[2]  Bernhard Sattler,et al.  PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  W. Oyen,et al.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  Barbara Vanderstraeten,et al.  Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[5]  H. Zaidi,et al.  Molecular PET/CT imaging-guided radiation therapy treatment planning. , 2009, Academic radiology.

[6]  Aswin L Hoffmann,et al.  Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer? , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Xavier Geets,et al.  Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  Joe Y. Chang,et al.  GTV spatial conformity between different delineation methods by 18FDG PET/CT and pathology in esophageal cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  S Mutic,et al.  A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[10]  I. Buvat,et al.  Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.

[11]  Daniela Thorwarth,et al.  A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia , 2005, Physics in medicine and biology.

[12]  M. Schwaiger,et al.  Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[13]  H. Thierens,et al.  Implementation of biologically conformal radiation therapy (BCRT) in an algorithmic segmentation-based inverse planning approach , 2006, Physics in medicine and biology.

[14]  M Alber,et al.  On biologically conformal boost dose optimization. , 2003, Physics in medicine and biology.

[15]  Sadek Nehmeh,et al.  Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.

[16]  Gig Mageras,et al.  Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.

[17]  Daniela Thorwarth,et al.  A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations. , 2007, International journal of radiation oncology, biology, physics.

[18]  Søren M Bentzen,et al.  Theragnostic imaging for radiation oncology: dose-painting by numbers. , 2005, The Lancet. Oncology.

[19]  M. Eble,et al.  Dose-escalation using intensity-modulated radiotherapy for prostate cancer--evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Josien P. W. Pluim,et al.  Image registration , 2003, IEEE Transactions on Medical Imaging.

[21]  H. Thierens,et al.  [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  Ellen Yorke,et al.  18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy* , 2009, Journal of Nuclear Medicine.

[23]  Ursula Nestle,et al.  Biological imaging in radiation therapy: role of positron emission tomography , 2009, Physics in medicine and biology.

[24]  Anne Bol,et al.  The limitation of PET imaging for biological adaptive-IMRT assessed in animal models. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  P. Grigsby,et al.  Prospective clinical trial of positron emission tomography/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes. , 2008, International journal of radiation oncology, biology, physics.

[26]  Jens Overgaard,et al.  Resolution in PET hypoxia imaging: Voxel size matters , 2008, Acta oncologica.

[27]  Matthias Reimold,et al.  Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  Wolfgang Enghardt,et al.  Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning? , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  Johannes A Langendijk,et al.  Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  David L. Schwartz,et al.  Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer , 2006, Clinical Cancer Research.

[31]  Daniela Thorwarth,et al.  Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  Robert Jeraj,et al.  On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function , 2009, Physics in medicine and biology.

[33]  W. Oyen,et al.  18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors , 2010, Journal of Nuclear Medicine.

[34]  Barbara Vanderstraeten,et al.  Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo, convolution/superposition, and pencil beam computations. , 2006, Medical physics.

[35]  Lester J. Peters,et al.  Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[36]  R. Haubner PET radiopharmaceuticals in radiation treatment planning - synthesis and biological characteristics. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[38]  Ping Xia,et al.  Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT? , 2009, International Journal of Radiation Oncology, Biology, Physics.

[39]  Ludy Lutgens,et al.  Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. , 2005, International journal of radiation oncology, biology, physics.

[40]  W. Oyen,et al.  18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients , 2007, Journal of Nuclear Medicine.

[41]  John L. Humm,et al.  Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging , 2008, Physics in medicine and biology.

[42]  Richard A Popple,et al.  Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. , 2002, International journal of radiation oncology, biology, physics.

[43]  Sadek Nehmeh,et al.  The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. , 2008, International journal of radiation oncology, biology, physics.

[44]  P. Lambin,et al.  Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  P. Keall 4-dimensional computed tomography imaging and treatment planning. , 2004, Seminars in radiation oncology.

[46]  Robert Jeraj,et al.  Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. , 2008, Physics in medicine and biology.

[47]  Daniela Thorwarth,et al.  Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.

[48]  Mark Muzi,et al.  [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure. , 2006, International journal of radiation oncology, biology, physics.

[49]  Tomio Inoue,et al.  Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[50]  Andrea Schaefer,et al.  A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[51]  Olivier Barret,et al.  Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[52]  X Allen Li,et al.  Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[53]  K Schnabel,et al.  18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. , 1999, International journal of radiation oncology, biology, physics.

[54]  J. Mountz,et al.  Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation , 2009, Nuclear medicine communications.

[55]  L. Bogner,et al.  A Biologically Adapted Dose-Escalation Approach, Demonstrated for 18F-FET-PET in Brain Tumors , 2008, Strahlentherapie und Onkologie.

[56]  Sigrid Stroobants,et al.  Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI , 2009, Journal of Nuclear Medicine.

[57]  Xavier Geets,et al.  Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[58]  P. Lambin,et al.  Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[59]  Andrew J Reader,et al.  The promise of new PET image reconstruction. , 2008, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[60]  Dag Rune Olsen,et al.  Strategies for biologic image-guided dose escalation: a review. , 2009, International journal of radiation oncology, biology, physics.

[61]  H. Minn,et al.  Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[62]  Habib Zaidi,et al.  18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[63]  M. Kessler,et al.  Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[64]  O. Hoekstra,et al.  Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[65]  J. Lee,et al.  Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  D. Mankoff,et al.  Hypoxia imaging-directed radiation treatment planning , 2006, European Journal of Nuclear Medicine and Molecular Imaging.